Related Experiment Video
Updated: May 9, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Progress in detecting genetic alterations and their association with human disease
Charles E Schwartz1, Chin-Fu Chen
1Greenwood Genetic Center, 113 Gregor Mendel Circle, Greenwood, SC 29646, USA.
The Human Genome Project enabled mutation detection, but next-generation sequencing (NGS) now allows rapid whole exome sequencing. Data analysis remains a challenge for linking genetic alterations to disorders.
Area of Science:
- Genomics and Genetic Medicine
- Molecular Biology and Bioinformatics
Background:
- The Human Genome Project provided a reference genome for identifying disease-causing mutations.
- Early methods like Sanger sequencing were time-consuming and limited in scope for large-scale genetic screening.
Purpose of the Study:
- To highlight the evolution of genetic sequencing technologies for disease mutation identification.
- To underscore the current challenges in analyzing massive datasets generated by next-generation sequencing.
Main Methods:
- Review of historical and current genetic sequencing methodologies, from Sanger sequencing to next-generation sequencing (NGS).
- Discussion of the technological advancements enabling whole exome sequencing of multiple individuals.
Main Results:
- Next-generation sequencing significantly reduced the time required for exome sequencing (approximately 10 days).
- The massive data output from NGS presents a significant bottleneck in identifying relevant genetic alterations.
Conclusions:
- While NGS has revolutionized the speed of genetic data generation, data filtering and analysis are critical rate-limiting steps.
- Efficient bioinformatics pipelines are essential for translating vast genomic data into clinically relevant findings for human disorders.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pharmacogenetics and Pharmacogenomics: Overview
Karyotyping

